.Pharmacolibrary.Drugs.V_Various.V09G_CardiovascularSystem.V09GX01_Thallium201tlChloride.Thallium201tlChloride .Pharmacolibrary.Drugs.V_Various.V09G_CardiovascularSystem.V09GX01_Thallium201tlChloride.Thallium201tlChloride| name: | Thallium201tlChloride | |
| ATC code: | V09GX01 | |
| route: | intravenous | |
| compartments: | 2 | |
| dosage: | 74 | mg |
| volume of distribution: | 0.13 | L |
| clearance: | 14 | mL/min/kg |
| other parameters in model implementation | ||
Thallium (201Tl) chloride is a radioactive diagnostic agent used primarily in nuclear medicine for myocardial perfusion imaging to detect areas of ischemia or infarct in the heart. It is not used as a therapeutic drug. Its use has declined due to the advent of newer agents such as technetium-99m compounds, but it is still approved and occasionally used today for specific diagnostic indications.
Estimated pharmacokinetics in healthy adults. Thallium-201 chloride is administered intravenously for scintigraphy. Detailed human pharmacokinetics are sparsely reported in the literature; values below are based on data referenced in review articles and package inserts.